PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Clinical and Molecular Hepatology10.3350/cmh.2013.19.2.1652013192165Efficacy and safety of entecavir plus carnitine complex (GODEX®) compared to entecavir monotherapy in patient with ALT elevated chronic hepatitis B: randomized, multicenter open-label trials. The GOAL studyDae Won Jun, Byung Ik Kim, Yong Kyun Cho, Hong Ju Kim, Young Oh Kwon, Soo Young Park, Sang Young Han, Yang Hyun Baek, Yong Jin Jung, Hwi Young Kim, Won Kim, Jeong Heo, Hyun Young Woo, Seong Gyu Hwang, Kyu Sung Rim, Jong Young Choi, Si Hyun Bae, Young Sang Lee, Young Suck Lim, Jae Youn Cheong, Sung Won Cho, Byung Seok Lee, Seok Hyun Kim, Joo Hyun Sohn, Tae Yeob Kim, Yong Han Paik, Ja Kyung Kim, Kwan Sik Leehttp://synapse.koreamed.org/pdf/10.3350/cmh.2013.19.2.165, http://synapse.koreamed.org/DOIx.php?id=10.3350/cmh.2013.19.2.165, http://www.e-cmh.org/upload/pdf/cmh-19-165.pdf
Infection and Drug Resistance10.2147/idr.s4188201155Safety and efficacy of entecavir for the treatment of chronic hepatitis BMelissa Osbornhttps://www.dovepress.com/getfile.php?fileID=8703
Intervirology10.1159/00035385120135718-16Long-Term Efficacy of Entecavir Plus Adefovir Combination Therapy versus Entecavir Monotherapy in Adefovir Refractory Chronic Hepatitis B Patients with Prior Lamivudine ResistanceSeung Young Seo, In Hee Kim, Ji Youn Sohn, Seok Lee, Seong Hun Kim, Sang Wook Kim, Seung Ok Lee, Soo Teik Lee, Dae-Ghon Kimhttps://www.karger.com/Article/Pdf/353851, https://www.karger.com/Article/Pdf/353851
Gastroenterology10.1016/s0016-5085(15)31685-120151484S-502Su1414 A Randomized Controlled Trial to Compare the Efficacy and Safety of Entecavir Versus Tenofovir Treatment in Naïve Chronic Hepatitis B PatientsTassanee Sriprayoonhttps://api.elsevier.com/content/article/PII:S0016508515316851?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0016508515316851?httpAccept=text/plain
Journal of Hepatology10.1016/s0168-8278(14)61202-22014601S422P1042 EFFICACY OF ENTECAVIR MONOTHERAPY VERSUS ENTECAVIR PLUS ADEFOVIR COMBINATION THERAPY AS RESCUE THERAPY FOR rt181 MUTANTS OF HEPATITIS B VIRUS: 48 WEEKS RESULTSM.J. Oh, H.J. Lee, K.H. Kim, K.O. Kim, S.H. Lee, B.I. Jang, T.N. Kimhttps://api.elsevier.com/content/article/PII:S0168827814612022?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0168827814612022?httpAccept=text/plain
Hepatology10.1002/hep.24361201154191-100Efficacy and safety of entecavir versus adefovir in chronic hepatitis B patients with hepatic decompensation: A randomized, open-label studyYun-Fan Liaw, Maria Raptopoulou-Gigi, Hugo Cheinquer, Shiv Kumar Sarin, Tawesak Tanwandee, Nancy Leung, Cheng-Yuan Peng, Robert P. Myers, Robert S. Brown, Lennox Jeffers, Naoky Tsai, Jolanta Bialkowska, Shijie Tang, Suzanne Beebe, Elizabeth Cooneyhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fhep.24361, http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.24361/fullpdf
Journal of Viral Hepatitis10.1111/jvh.12333_2920142138-39P30: Entecavir has high efficacy and safety in Caucasian patients with chronic hepatitis B and co-morbiditieshttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fjvh.12333_29, https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fjvh.12333_29, http://onlinelibrary.wiley.com/wol1/doi/10.1111/jvh.12333_29/fullpdf
Journal of Korean Medical Science10.3346/jkms.2018.33.e632018338A Multicenter Study of the Antiviral Efficacy of Entecavir Monotherapy Compared to Lamivudine Monotherapy in Children with Nucleos(t)ide-naïve Chronic Hepatitis BKyung Jae Lee, Byung-Ho Choe, Jae Young Choe, Ju Young Kim, In Sook Jeong, Ju Whi Kim, Hye Ran Yang, Ju Yuong Chang, Kyung Mo Kim, Jin Soo Moon, Jae Sung Kohttps://synapse.koreamed.org/pdf/10.3346/jkms.2018.33.e63, https://synapse.koreamed.org/DOIx.php?id=10.3346/jkms.2018.33.e63, https://jkms.org/DOIx.php?id=10.3346/jkms.2018.33.e63
Acta Ophthalmologica10.1111/j.1755-3768.2012.2826.x2012900-0Prospective, randomized, multicenter, open label, phase II / III study to assess efficacy and safety of ranibizumab 0.5 mg intravitreal injections plus panretinal photocoagulation (PRP) versus and PRP in monotherapy in the treatment of patients with highJ FIGUEIRAhttp://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1755-3768.2012.2826.x, http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1755-3768.2012.2826.x/fullpdf
Clinical Therapeutics10.1016/j.clinthera.2012.07.00120123481720-1734.e3I-ADD Study: Assessment of Efficacy and Safety Profile of Irbesartan/Amlodipine Fixed-Dose Combination Therapy Compared With Irbesartan Monotherapy in Hypertensive Patients Uncontrolled With Irbesartan 150 mg Monotherapy: A Multicenter, Phase III, Prospective, Randomized, Open-Label With Blinded–End Point Evaluation StudyGuillaume Bobriehttps://api.elsevier.com/content/article/PII:S0149291812004274?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0149291812004274?httpAccept=text/plain